Peginterferon alfa-2a

Peginterferon alfa-2a is a pegylated form of interferon alfa-2a, a type of interferon used as an antiviral and antineoplastic agent. It is primarily used in the treatment of hepatitis C and hepatitis B infections. Peginterferon alfa-2a is marketed under the brand name Pegasys.

Mechanism of Action

Peginterferon alfa-2a works by binding to specific receptors on the surface of cells, initiating a complex cascade of intracellular events. This leads to the activation of multiple genes that inhibit viral replication and modulate the immune response. The pegylation process, which involves attaching a polyethylene glycol (PEG) molecule to the interferon, increases the half-life of the drug, allowing for less frequent dosing compared to non-pegylated interferons.

Indications

Peginterferon alfa-2a is indicated for the treatment of:

• Chronic hepatitis C (CHC) in patients with compensated liver disease.
• Chronic hepatitis B (CHB) in patients with compensated liver disease and evidence of viral replication and liver inflammation.

Administration and Dosage

Peginterferon alfa-2a is administered via subcutaneous injection. The dosage and duration of treatment vary depending on the condition being treated and the patient's response to therapy. For chronic hepatitis C, it is often used in combination with ribavirin.

Side Effects

Common side effects of peginterferon alfa-2a include:

• Flu-like symptoms (fever, chills, muscle aches)
• Fatigue
• Depression
• Insomnia
• Anorexia
• Nausea
• Injection site reactions

Serious side effects can include:

• Severe depression and suicidal ideation
• Autoimmune disorders
• Infections
• Bone marrow suppression

Contraindications

Peginterferon alfa-2a is contraindicated in patients with:

• Hypersensitivity to interferon alfa or any component of the formulation
• Autoimmune hepatitis
• Decompensated liver disease

Related Pages

• Interferon
• Hepatitis C
• Hepatitis B
• Ribavirin
• Antiviral drug
• Polyethylene glycol

See Also

• List of antiviral drugs
• List of hepatitis C treatments

External Links

Peginterferon alfa-2a
INN
Drug class
Routes of administration	Subcutaneous injection
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

   This article is a medical stub. You can help WikiMD by expanding it!